Medical teams at Texas Children’s Hospital in Houston have completed a groundbreaking surgical procedure to repair a serious birth defect in utero. The patient, baby Theo, had gastroschisis, a condition in which the abdominal wall fails to develop properly, causing internal organs to grow externally. Theo’s mother, Maisie Savage, underwent the innovative operation while carrying him at 26 weeks of gestation. He was the third baby worldwide to benefit from this first-of-its-kind clinical trial.
Gastroschisis affects one in 3,000 UK babies annually. Untreated cases typically require extensive neonatal intensive care, multiple surgeries, and tube or intravenous feeding for extended periods. In severe cases, infants may need intestinal transplants, with mortality rates reaching one in 10 even with optimal medical intervention. Theo’s case was classified as complex gastroschisis, prompting his family to seek specialized care in the United States.
The surgical approach involved a multi-step process. Prior to the main operation, Maisie received a Botox injection into Theo’s abdominal wall at a Belgian hospital to relax the muscles. During the procedure in November, surgeons partially exposed the uterus, drained the amniotic fluid, and replaced it with carbon dioxide gas to create working space. Using minimally invasive keyhole techniques, they repositioned Theo’s organs inside his abdomen and closed the opening. The operation proceeded without complications.
Theo was born in February by vaginal delivery in Texas and is currently five months old. Medical teams reported zero complications during and after the fetal surgery. The successful outcome has opened discussions about expanding the procedure’s availability internationally, with specialists at London’s Great Ormond Street Hospital expressing interest in offering the treatment within the UK healthcare system.
Dr. Michael Belfort, clinical lead of the trial, noted that the womb represents a new surgical frontier for treating multiple conditions. Beyond gastroschisis and spina bifida, he indicated potential applications for fetal cardiac and lung surgeries in utero.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI